De Wolf MJF - Search Results

1

Comparison of Long-Term Microscopic and Endoscopic Audiologic Results After Total Ossicular Replacement Prosthesis Surgery.

Baazil AHA, Ebbens FA, van Spronsen E, De Wolf MJF, Dikkers FG. Baazil AHA, et al. Among authors: de wolf mjf. Otol Neurotol. 2022 Dec 1;43(10):1189-1195. doi: 10.1097/MAO.0000000000003733. Otol Neurotol. 2022. PMID: 36302389 Free PMC article.

2

Clinical outcome of the simplified surgical technique for BAHA implantation.

de Wolf MJ, Hol MK, Huygen PL, Mylanus EA, Cremers CW. de Wolf MJ, et al. Otol Neurotol. 2008 Dec;29(8):1100-8. doi: 10.1097/MAO.0b013e31818599b8. Otol Neurotol. 2008. PMID: 18800022

3

Age-related use and benefit of the bone-anchored hearing aid compact.

de Wolf MJ, Leijendeckers JM, Mylanus EA, Hol MK, Snik AF, Cremers CW. de Wolf MJ, et al. Otol Neurotol. 2009 Sep;30(6):787-92. doi: 10.1097/MAO.0b013e3181b120ea. Otol Neurotol. 2009. PMID: 19638942

4

Bilateral bone-anchored hearing aid application in children: the Nijmegen experience from 1996 to 2008.

Dun CA, de Wolf MJ, Mylanus EA, Snik AF, Hol MK, Cremers CW. Dun CA, et al. Otol Neurotol. 2010 Jun;31(4):615-23. doi: 10.1097/MAO.0b013e3181dbb37e. Otol Neurotol. 2010. PMID: 20393374

5

Benefit and quality of life in older bone-anchored hearing aid users.

de Wolf MJ, Shival ML, Hol MK, Mylanus EA, Cremers CW, Snik AF. de Wolf MJ, et al. Otol Neurotol. 2010 Jul;31(5):766-72. doi: 10.1097/MAO.0b013e3181e3d740. Otol Neurotol. 2010. PMID: 20581615

6

Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigation.

Dun CA, de Wolf MJ, Hol MK, Wigren S, Eeg-Olofsson M, Green K, Karlsmo A, Flynn MC, Stalfors J, Rothera M, Mylanus EA, Cremers CW. Dun CA, et al. Otol Neurotol. 2011 Aug;32(6):1001-7. doi: 10.1097/MAO.0b013e3182267e9c. Otol Neurotol. 2011. PMID: 21725257 Clinical Trial.

7

Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival.

Dun CA, Faber HT, de Wolf MJ, Mylanus EA, Cremers CW, Hol MK. Dun CA, et al. Otol Neurotol. 2012 Feb;33(2):192-8. doi: 10.1097/MAO.0b013e318241c0bf. Otol Neurotol. 2012. PMID: 22246385

8

Titanium fixtures for bone-conduction devices and the influence of type 2 diabetes mellitus.

Horstink L, Faber HT, de Wolf MJ, Dun CA, Cremers CW, Hol MK. Horstink L, et al. Otol Neurotol. 2012 Aug;33(6):1013-7. doi: 10.1097/MAO.0b013e318259b36c. Otol Neurotol. 2012. PMID: 22722143

9

Long-term stability, survival, and tolerability of a novel osseointegrated implant for bone conduction hearing: 3-year data from a multicenter, randomized, controlled, clinical investigation.

Nelissen RC, Stalfors J, de Wolf MJ, Flynn MC, Wigren S, Eeg-Olofsson M, Green K, Rothera MP, Mylanus EA, Hol MK. Nelissen RC, et al. Otol Neurotol. 2014 Sep;35(8):1486-91. doi: 10.1097/MAO.0000000000000533. Otol Neurotol. 2014. PMID: 25080037 Clinical Trial.

10

A Retrospective Cohort Study on the Influence of Comorbidity on Soft Tissue Reactions, Revision Surgery, and Implant Loss in Bone-anchored Hearing Implants.

den Besten CA, Nelissen RC, Peer PG, Faber HT, Dun CA, de Wolf MJ, Kunst HP, Cremers CW, Mylanus EA, Hol MK. den Besten CA, et al. Otol Neurotol. 2015 Jun;36(5):812-8. doi: 10.1097/MAO.0000000000000745. Otol Neurotol. 2015. PMID: 25811351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters